MUC17 and laryngeal carcinoma: We anticipate that by targeting mucin‐overexpressing laryngeal cancer cells, the chitosan‐coated liposomes will electrostatically bind to transmembrane mucins like MUC1, MUC4, MUC17 and thus enhance the drug intake and retention process.108, 109